Search

for
Search:

Glossary

Similar Terms

Fibrin Degradation Product

Learn

0 / 0 results

— no results

Research

5 / 52 results

research The Mesenchymal Component of Hair Follicle Neogenesis: Background, Methods, and Molecular Characterization

131 citations , July 2009 in “Experimental Dermatology”

The document concludes that specific cells are essential for hair growth and more research is needed to understand how to maintain their hair-inducing properties.

research Transcriptomic Profiling of Frontal and Occipital Dermal Papilla Reveals Potential Role of TRPS1 in Androgenic Alopecia

July 2022 in “Journal of Investigative Dermatology”

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

research Fibroblast Heterogeneity: Implications for Human Disease

299 citations , January 2018 in “Journal of Clinical Investigation”

Different types of fibroblasts play various roles in diseases and healing, and more research on them could improve treatments.

research Tissue Engineering and Regeneration of the Human Hair Follicle in Androgenetic Alopecia: Literature Review

4 citations , January 2022 in “Life”

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

research Perspectives on Hair Evolution Based on Comparative Studies on Vertebrate Cornification

17 citations , June 2012 in “Journal of experimental zoology. Part B, Molecular and developmental evolution”

Hair in mammals likely evolved from glandular structures, not scales.

View more "fdp cells" in research →

Community Join

1 / 1 results

community Why is everyone not directly advised Dutasteride?

in Finasteride/Dutasteride 169 upvotes 1 year ago

Dutasteride is less commonly prescribed for hair loss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.